Global Biofeedback Measurement Instrument Market, by Type (Brainwaves, Heart Rate, Muscles, Sweat Glands, and Others), by End User (Hospitals, Clinics, Home Settings, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 148.68 million in 2019, and is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Biofeedback is the use of electronic or electromechanical equipment (usually computer-based) that helps to measure and provide feedback about physiological processes. The aim of biofeedback is to make patients aware about the different states of physiologic arousal and patients’ ability to control physiologic changes in their bodies. Goals of biofeedback treatment also includes improvement of the pediatric patient's ability to distinguish and cultivate lower levels of sympathetic nervous system arousal and achieve a balanced state of mind-body.

The increasing incidence of neurological disorders is expected to propel growth of the market during the forecast period. For instance, according to a report published by the World Health Organization (WHO) in 2016, there are 7.7 million new cases of dementia every year across the globe. Moreover, Alzheimer’s disease, which is the most common cause of dementia, accounts for 60 to 70% of dementia cases. Furthermore, according to the Mindgardens Neuroscience Network, the leading cause of disability in Australia in 2017 was mental and neurological disorders, which accounted for 20.5% of the total Australian daily adjusted life years (DALYs).

Browse 20 Market Data Tables and 16 Figures spread through 150 Pages and in-depth TOC on “Biofeedback Measurement Instrument Market” - Global forecast to 2027, by Type (Brainwaves, Heart Rate, Muscles, Sweat Glands, and Others), by End User (Hospitals, Clinics, Home Settings, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Biofeedback Measurement Instrument Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/biofeedback-measurement-instrument-market-3781

Asia Pacific is expected to offer lucrative growth opportunities for players operating in the biofeedback measurement instrument market owing to the rising incidence of CNS disorders in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in 2018 reports that the burden of dementia in Japan is growing and it is expected that 1 in 5 elderly people will suffer from dementia in Japan by 2025.

Moreover, the growing patient pool with neurological disorders in this region is expected to drive growth of the market during the forecast period. For instance, according to the Mindgardens Neuroscience Network, in 2017, the total prevalence of neurological disorders in Australia was 10.6 million (43.0%), followed by 4 million (16.3%) for mental health disorders, and 0.8 million (3.2.0%) for substance disorders.

Key Takeaways of the Biofeedback Measurement Instrument Market:

  • The global biofeedback measurement instrument market is expected to exhibit a CAGR of 6.2% over the forecast period owing to an increasing number of depression cases. According to Our World in Data – a project of the Global Change Data Lab, the study estimates that in 2017, nearly 792 million people were suffering with mental health disorder in 2017 in North America.
  • Among type segment, brainwaves held dominant position in the biofeedback measurement instrument market in 2018 owing to the rising incidence of mental disorders. According to the Global Burden of Disease, in 2017 there were 264 million individuals were suffering through depression.
  • Among end user, hospitals segment held dominant position in the biofeedback measurement instrument market in 2019 owing to growing number neurological disorders. For instance, according to the Mindgardens Neuroscience Network, in 2017, neurological, mental health, and substance abuse disorders accounted for 11.1% of the global burden of disease.
  • The companies operating in the global biofeedback measurement instrument market are Thought Technology Ltd., ELMIKO, Mind Media, Laborie, Behavioral Medicine Associates, Inc., Neurocare Group Gmbh., Allengers Medical Systems, BrainMaster Technologies, Inc., Quantum World Vision, NCC Medical, Qxsubspace, and others.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner